Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds

In a first-of-its-kind objective trial, U.S. researchers recovered that radical with agitation and dementia successful precocious beingness who took a peculiar aesculapian formulation of 2 progressive ingredients recovered successful marijuana—THC and CBD—had importantly little agitation than radical who received a placebo.